In a post hoc analysis of two phase 3 trials, researchers set out to determine the impact of sex on tofacitinib in terms of efficacy, safety, and time to discontinuation.
In a post hoc analysis of the EXCEED study, researchers found that secukinumab and adalimumab—two biologic disease-modifying antirheumatic medications—showed similar efficacy in the resolution of enthesitis...
Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.
To better understand the potential benefits of secukinumab use in patients with psoriatic arthritis, researchers examined the proportion of patients being treated with secukinumab that achieved low disease...
The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.
Researchers conducted a trial to investigate the use of cannabidiol (CBD) to help manage pain in patients with psoriatic arthritis and hand osteoarthritis.
The authors of a recent study aimed to determine if the use of routine ultrasound could be an effective tool for screening patients with psoriasis for subclinical psoriatic arthritis.
Researchers compared if early initiation of disease modifying antirheumatic drugs for the treatment of psoriatic arthritis was superior to later initiation of therapy after diagnosis in a recent study...
In a recent study presented at ACR Convergence 2022, researchers compared the rates of improvement and associated outcomes of upadacitinib with adalimumab for the treatment of individuals with psoriatic...
